Endogenous opioid peptides and mental stress in congestive heart failure patients

Peptides

Volumn 19, Issue 1, 1998, Pages 21-26

  Fontana, Fiorella ^a   Bernardi, Pasquale ^a   Merlo Pich, Emilio ^b   Boschi, Stefano ^c   De Iasio, Rosaria ^c   Spampinato, Santi ^d  

^a Dipartimento di Medicina Interna   (Italy)

^b GlaxoSmithKline   (Switzerland)

^c UNIVERSITY OF BOLOGNA   (Italy)

^d Dipartimento di Biochimica   (Italy)

Author keywords

endorphin; Atrial natriuretic factor; Congestire heart failure; Dynorphin B; Endothelin 1; Mental Arithmetic Test; Met enkephalin; Naloxone; Norepinephrine

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BETA ENDORPHIN; DYNORPHIN; ENDOTHELIN 1; METENKEPHALIN; NALOXONE; NORADRENALIN; OPIATE PEPTIDE; PLACEBO;

ACUTE HEART FAILURE; ADULT; ARITHMETIC; ARTICLE; BLOOD PRESSURE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEART RATE; HEART RHYTHM; HUMAN; MALE; MENTAL STRESS; NEUROENDOCRINOLOGY; NORADRENALIN BLOOD LEVEL; NORADRENALIN RELEASE; PRIORITY JOURNAL;

ATRIAL NATRIURETIC FACTOR; BETA-ENDORPHIN; BLOOD PRESSURE; ENDOTHELIN-1; ENKEPHALIN, METHIONINE; FEMALE; HEART FAILURE, CONGESTIVE; HEART RATE; HEMODYNAMIC PROCESSES; HUMANS; INTELLIGENCE TESTS; MALE; MIDDLE AGED; NALOXONE; NARCOTIC ANTAGONISTS; NOREPINEPHRINE; OPIOID PEPTIDES; STRESS;

EID: 0031913852     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-9781(97)00251-9     Document Type: Article

References (33)

1. Bernardi P., Fontana F., Merlo Pich E., Spampinato S., Canossa S. Plasma endogenous opioid levels in acute myocardial infarction patients, with and without pain. Eur. Heart J. 13:1992;1074-1079.
2. Braunwald E. Pathophysiology of heart failure. Braunwald E. Heart disease. 1980;453-471 W.B. Saunders Company, A textbook of cardiovascular medicine. Philadelphia.
3. Chalmers J., Pilowsky P. Brainstem and bulbospinal neurotransmitter systems in the control of blood pressure. J. Hypertens. 9:1991;675-694.
4. Farrell P. A., Gates W. K., Maksud M. G., Morgan W. P. Increases in plasma β-endorphin/β-lipotrophin immunoreactivity after treadmill running in humans. J. Appl. Physiol. 52:1982;1245-1249.
5. Feigenbaum H. Echocardiography. 1976;Lea and Febinger Press, Philadelphia.
6. Fontana F., Bernardi P., Spagnolo N., Capelli M. Plasma atrial natriuretic factor in low output heart failure syndromes. Klin. Wochenschr. 68:1990;313-319.
7. Fontana F., Bernardi P., Merlo Pich E., Capelli M., Bortoluzzi L., Spampinato S., Canossa M. Relationship between plasma atrial natriuretic factor and opioid peptide levels in healthy subjects and in patients with congestive heart failure. Eur. Heart J. 14:1993;219-225.
8. Fontana F., Bernardi P., Spampinato S., Boschi S., De Iasio R., Grossi G. Pressor effects of endogenous opioid system during acute episodes of blood pressure increases in hypertensive patients. Hypertension. 29:1997;105-110.
9. Fontana F., Bernardi P., Merlo Pich E., Boschi S., De Iasio R., Spampinato S., Grossi G. Opioid peptide modulation of circulatory and endocrine response to mental stress in humans. Peptides. 18:1997;169-175.
10. Giannuzzi P., Shabetai R., Imparato A., Temporelli P. L., Bhargava V., Cremo R., Tavazzi L. Effects of mental exercise in patients with dilated cardiomyopathy and congestive heart failure. An echocardiographic doppler study. Circulation. 83:(suppl. 2):1991;155-165.
11. Grossi G., Bargossi A. M., Lucarelli C., Paradisi R., Sprovieri C., Sprovieri G. Improvements in automated analysis of catecholamine and related metabolites in biological samples by column switching high-performance liquid chromatography. J. Chromatogr. 541:1991;273-284.
12. Hara H., Ogihara T., Shima J., Saito H., Rakugi H., Iinuma K., Kumahara Y., Minamino T. Plasma atrial natriuretic peptide level as an index for the severity of congestive heart failure. Clin. Cardiol. 10:1987;437-442.
13. Hirata Y., Itoh K. I., Ando K., Endo M., Marumo F. Plasma endothelin levels during surgery. N. Engl. J. Med. 321:1989;1686.
14. Kapusta D. R., Jones S. Y., DiBona G. F. Opioids in the systemic hemodynamic and renal responses to stress in conscious spontaneously hypertensive rats. Hypertension. 13:1989;808-816.
15. Klein R., Wilson S., Dzielak D. Opioids and norepinephrine appear to be co-stored in large dense-core vescicles of sympathetic nerve. Fed. Proc. 41:1981;1076.
16. Leino T., Leppaluoto J., Huttunen P., Ruokonen A., Kuronen P. Neuroendocrine responses to real and simulated BA Hawk MK 51 flight. Aviat. Space Environ. Med. 66:1995;108-113.
17. Lindvall K., Kahan T., de Faire U., Ostergren J., Hjemdahl P. Stress-induced changes in blood pressure and left ventricular function in mild hypertension. Clin. Cardiol. 14:1991;125-132.
18. Livett B. G., Day R., Elde R. P., Howe P. R. C. Co-storage of enkephalins and adrenaline in bovine adrenal medulla. Neuroscience. 7:1982;1323-1332.
19. Louisy F., Guezennec C. Y., Lartigue M., Aldigier J. C., Galen F. X. Influence of endogenous opioids on atrial natriuretic factor release during exercise in man. Eur. J. Appl. Physiol. 59:1989;34-38.
20. Mazzuero G., Temporelli P. L., Tavazzi L. Influence of mental stress on ventricular pump function in postinfarction patients. An invasive hemodynamic investigation. Circulation. 83:(suppl. 2):1991;145-154.
21. McCubbin J. A., Surwit R. S., Williams R. B., Nemeroff C. B., McNelly M. Altered pituitary hormone response to naloxone in hypertension development. Hypertension. 14:1989;636-644.
22. Miller W. L., Redfield M. M., Burnett J. C. Jr. Integrated cardiac, renal, and endocrine actions of endothelin. J. Clin. Invest. 83:1989;317-320.
23. Naranjo J. R., Urdin M. C., Borrell J., Fuentes J. A. Evidence for a central but not adrenal, opioid mediation in hypertension induced by brief isolation. Life Sci. 38:1986;1923-1930.
24. Packer M. The neurohormonal hypothesis a theory to explain the mechanism of disease progression in heart failure . J. Am. Coll. Cardiol. 20:1992;248-254.
25. Pesonen A., Leppaluoto J., Ruskoaho H. Mechanism of opioid-induced atrial natriuretic peptide release in conscious rats. J. Pharmacol. Exp. Ther. 254:1990;690-695.
26. Rakugi H., Tabuchi Y., Nakamaru M., Nagano M., Higashimori K., Mikami H., Ogihara T., Suzuki N. Evidence for endothelin-1 release from resistance vessels of rats in response to hypoxia. Biochem. Biophys. Res. Commun. 169:1990;973-977.
27. Roy L. F., Ogilva R. I., Larochelle P., Hamet P., Leene F. H. H. Cardiac and vascular effects of atrial natriuretic factor and sodium nitroprusside in healthy men. Circulation. 79:1989;383-392.
28. Specchia G., Falcone C., Traversi E., LaRouere M. T., Guasti L., De Micheli G., Ardissino D., De Servi S. Mental stress as a provocative test in patients with various syndromes of coronary heart disease. Circulation. 83:(suppl. II):1991;108-114.
29. Stewart D. J., Cernacek P., Costello K. B., Rouleau J. L. Elevated endothelin-1 in heart failure and loss of normal response to postural change. Circulation. 85:1992;510-517.
30. Thomas J. A., Marks B. H. Plasma norepinephrine in congestive heart failure. Am. J. Cardiol. 41:1978;233-243.
31. Ushiyama K., Ogawa T., Ishii M., Ajisaka R., Sugishita Y., Ito I. Physiologic neuroendocrine arousal by mental arithmetic stress test in healthy subjects. Am. J. Cardiol. 67:1991;101-103.
32. Winquist R. J. The relaxant effects of atrial natriuretic factor on vascular smooth muscle. Life Sci. 37:1985;1081-1087.
33. Yanagisawa M., Kurihara H., Kimura S., Tomobe Y., Kobayashi M., Mitsui Y., Yazaki Y., Goto K., Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature. 332:1988;411-415.